These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33772480)

  • 1. Fibrinolysis in Patients with Liver Disease.
    von Meijenfeldt FA; Lisman T
    Semin Thromb Hemost; 2021 Jul; 47(5):601-609. PubMed ID: 33772480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fibrinolytic Status in Liver Diseases.
    Leebeek FW; Rijken DC
    Semin Thromb Hemost; 2015 Jul; 41(5):474-80. PubMed ID: 26049070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfibrinolysis in liver disease.
    Ferro D; Celestini A; Violi F
    Clin Liver Dis; 2009 Feb; 13(1):21-31. PubMed ID: 19150306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival.
    Blasi A; Patel VC; Adelmeijer J; Azarian S; Hernandez Tejero M; Calvo A; Fernández J; Bernal W; Lisman T
    Hepatology; 2020 Apr; 71(4):1381-1390. PubMed ID: 31465557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests.
    Rijken DC; Kock EL; Guimarães AH; Talens S; Darwish Murad S; Janssen HL; Leebeek FW
    J Thromb Haemost; 2012 Oct; 10(10):2116-22. PubMed ID: 22906184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding Disorders in Primary Fibrinolysis.
    Franchini M; Zaffanello M; Mannucci PM
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of hyperfibrinolysis in cats and dogs.
    Birkbeck R; Humm K; Cortellini S
    J Small Anim Pract; 2019 Nov; 60(11):641-655. PubMed ID: 31608455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
    Hu KQ; Yu AS; Tiyyagura L; Redeker AG; Reynolds TB
    Am J Gastroenterol; 2001 May; 96(5):1581-6. PubMed ID: 11374703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis and bleeding of unknown cause.
    Mehic D; Pabinger I; Ay C; Gebhart J
    Res Pract Thromb Haemost; 2021 May; 5(4):e12511. PubMed ID: 34027290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotting abnormalities in chronic liver disease.
    Violi F; Ferro D; Quintarelli C; Saliola M; Cordova C; Balsano F
    Dig Dis; 1992; 10(3):162-72. PubMed ID: 1611712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage.
    Boks AL; Brommer EJ; Schalm SW; Van Vliet HH
    Hepatology; 1986; 6(1):79-86. PubMed ID: 3943792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.
    Violi F; Ferro D
    Semin Thromb Hemost; 2013 Jun; 39(4):426-33. PubMed ID: 23487343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients.
    Steib A; Gengenwin N; Freys G; Boudjema K; Levy S; Otteni JC
    Br J Anaesth; 1994 Nov; 73(5):645-8. PubMed ID: 7826793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bleeding in patients with liver disease.
    Northup PG; Lisman T; Roberts LN
    J Thromb Haemost; 2021 Jul; 19(7):1644-1652. PubMed ID: 33974330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes.
    Basili S; Raparelli V; Violi F
    Eur J Intern Med; 2010 Apr; 21(2):62-4. PubMed ID: 20206871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGA Clinical Practice Update: Coagulation in Cirrhosis.
    O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
    Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperfibrinolysis: Facts and fancies.
    Franchini M; Mannucci PM
    Thromb Res; 2018 Jun; 166():71-75. PubMed ID: 29665524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis abnormalities in liver cirrhosis: myth or reality?
    Tripodi A
    Pol Arch Med Wewn; 2008; 118(7-8):445-8. PubMed ID: 18714742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.